论文部分内容阅读
目的:探讨糖尿病视网膜病变采用全视网膜光凝与复方樟柳碱联合治疗临床效果。方法:先取糖尿病视网膜病变患者60例,均为我院眼科2014年5月—2015年5月收治,依据入院先后顺序分组,就全视网膜光凝治疗(对照组,n=30)与加用复方樟柳碱联合治疗(观察组,n=30)效果展开对比。结果:该次研究观察组选取的糖尿病视网膜病变患者有效率为96.7%,明显高于对照组70%,有显著统计学差异(P<0.05)。两组视野、视网膜振荡电位、最佳矫正视力在治疗前无明显差异(P>0.05),治疗后均有改善,但观察组情况显著优于对照组,差异有统计学意义(P<0.05)。结论:针对糖尿病视网膜病变患者,在全视网膜光凝治疗基础上,加用复方樟柳碱治疗,可促视力水平恢复,为患者生存质量的提高提供了强有力的保障。
Objective: To investigate the clinical effect of panretinal photocoagulation combined with compound anisodine in the treatment of diabetic retinopathy. Methods: Sixty patients with diabetic retinopathy were selected. All of them were admitted to our department from May 2014 to May 2015, and were divided into two groups according to admission sequence. The patients in the control group (n = 30) The combination of anisodine (observation group, n = 30) results were compared. Results: The effective rate of diabetic retinopathy patients in this study group was 96.7%, which was significantly higher than that of the control group (70%) (P <0.05). The visual acuity, retinal oscillatory potential and best corrected visual acuity in the two groups had no significant difference before treatment (P> 0.05), but all were improved after treatment. However, the observation group was significantly better than the control group (P <0.05) . Conclusion: For patients with diabetic retinopathy, based on panretinal photocoagulation combined with compound anisodine treatment can promote the recovery of visual acuity, which provides a powerful guarantee for the improvement of patients’ quality of life.